No credit card. No commitment.
5000+ G2 reviews
Targepeutics
Research
Hershey, Pennsylvania
targepeutics.comTargepeutics
ResearchHershey, Pennsylvania
EmployeesTargepeutics' financial review
Targepeutics' Revenue (Yearly)
8.1M
Employees
3
Targepeutics information
Targepeutics is a biopharmaceutical company developing selective molecularly targeted therapeutics to fight and diagnose cancer and other diseases. Our lead compound, GB-13, is currently advancing toward a Phase I clinical trial for several cancer targets. GB-13 is a genetically engineered recombinant protein that specifically binds and destroys cancer cells with minimal normal cell damage. We ...
Targepeutics is a biopharmaceutical company developing selective molecularly targeted therapeutics to fight and diagnose cancer and other diseases. Our lead compound, GB-13, is currently advancing toward a Phase I clinical trial for several cancer targets. GB-13 is a genetically engineered recombinant protein that specifically binds and destroys cancer cells with minimal normal cell damage. We have also licensed related technology for a cancer immunotherapy that is in Phase III clinical trials.
Targepeutics industries
Cancer & precision medicine
Research
Biotechnology research
Targepeutics' financial review
Targepeutics' Revenue (Yearly)
8.1M
Employees
3
Employee Metrics
Technologies
Email Providers
Hosting
Other
Other
Content Management Platform
Notable Alumni
Employees
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download Extension
Why our clients choose Apollo
“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Erik Straub
Head of Product, Kickfurther
“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
Michael Transon
CEO, Victorious
